Published online before print March 23, 2006, doi: 10.1161/01.RES.0000218454.76784.66
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2006 American Heart Association, Inc.
Integrative Physiology |
Postinfarct Cytokine Therapy Regenerates Cardiac Tissue and Improves Left Ventricular Function
From the Institute of Molecular Cardiology (B.D., Y. Guo, A.R., A.B.S., G.H., S.T., J.V., Y. Gu, S.D.P., R.B.) and Institute of Cellular Therapeutics (Y.H., S.T.I.), University of Louisville, Kentucky; and Cardiovascular Research Institute (J.K., P.A.), Department of Medicine, New York Medical College, Valhalla.
Correspondence to Roberto Bolli, MD, Division of Cardiology, University of Louisville, Louisville, KY 40292. E-mail rbolli{at}louisville.edu
We systematically investigated the comparative efficacy of three different cytokine regimens, administered after a reperfused myocardial infarction, in regenerating cardiac tissue and improving left ventricular (LV) function. Wild-type (WT) mice underwent a 30-minute coronary occlusion followed by reperfusion and received vehicle, granulocyte colony-stimulating factor (G-CSF)+Flt-3 ligand (FL), G-CSF+stem cell factor (SCF), or G-CSF alone starting 4 hours after reperfusion. In separate experiments, chimeric mice generated by reconstitution of radioablated WT mice with bone marrow from enhanced green fluorescent protein (EGFP) transgenic mice underwent identical protocols. Mice were euthanized 5 weeks later. Echocardiographically, LV function was improved in G-CSF+FL– and G-CSF+SCF–treated but not in G-CSF–treated mice, whereas LV end-diastolic dimensions were smaller in all three groups. Morphometrically, cytokine-treated hearts had smaller LV diameter and volume. Numerous EGFP-positive cardiomyocytes, capillaries, and arterioles were noted in the infarcted region in cytokine-treated chimeric mice treated with G-CSF+FL or G-CSF+SCF, but the numbers were much smaller in G-CSF–treated mice. G-CSF+FL therapy mobilized bone marrow–derived cells exhibiting increased expression of surface antigens (CD62L and CD11a) that facilitate homing. We conclude that postinfarct cytokine therapy with G-CSF+FL or G-CSF+SCF limits adverse LV remodeling and improves LV performance by promoting cardiac regeneration and probably also by exerting other beneficial actions unrelated to regeneration, and that G-CSF alone is less effective.
Key Words: myocardial regeneration • cytokine • stem cell • ischemia/reperfusion • bone marrow • left ventricular function
Related Article:
Circ. Res. 2006 98: 990-992.
This article has been cited by other articles:
 |
|
 |
|
  V. Enzmann, E. Yolcu, H. J. Kaplan, and S. T. Ildstad Stem Cells as Tools in Regenerative Therapy for Retinal Degeneration Arch Ophthalmol, April 1, 2009; 127(4): 563 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M.A. Lombaert, J. F. Brunsting, P. K. Wierenga, H. H. Kampinga, G. de Haan, and R. P. Coppes Cytokine Treatment Improves Parenchymal and Vascular Damage of Salivary Glands after Irradiation Clin. Cancer Res., December 1, 2008; 14(23): 7741 - 7750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Cheng, L. Ou, Y. Liu, X. Liu, F. Li, B. Sun, Y. Che, D. Kong, Y. Yu, and G. Steinhoff Granulocyte colony-stimulating factor exacerbates cardiac fibrosis after myocardial infarction in a rat model of permanent occlusion Cardiovasc Res, December 1, 2008; 80(3): 425 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Dawn, S. Tiwari, M. J. Kucia, E. K. Zuba-Surma, Y. Guo, S. K. SanganalMath, A. Abdel-Latif, G. Hunt, R. J. Vincent, H. Taher, et al. Transplantation of Bone Marrow-Derived Very Small Embryonic-Like Stem Cells Attenuates Left Ventricular Dysfunction and Remodeling After Myocardial Infarction Stem Cells, June 1, 2008; 26(6): 1646 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Smart and P. R. Riley The Stem Cell Movement Circ. Res., May 23, 2008; 102(10): 1155 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Li, N. Naqvi, E. Yahiro, K. Liu, P. C. Powell, W. E. Bradley, D. I.K. Martin, R. M. Graham, L. J. Dell'Italia, and A. Husain c-kit Is Required for Cardiomyocyte Terminal Differentiation Circ. Res., March 28, 2008; 102(6): 677 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gandia, A. Arminan, J. M. Garcia-Verdugo, E. Lledo, A. Ruiz, M D. Minana, J. Sanchez-Torrijos, R. Paya, V. Mirabet, F. Carbonell-Uberos, et al. Human Dental Pulp Stem Cells Improve Left Ventricular Function, Induce Angiogenesis, and Reduce Infarct Size in Rats with Acute Myocardial Infarction Stem Cells, March 1, 2008; 26(3): 638 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tateishi, E. Ashihara, N. Takehara, T. Nomura, S. Honsho, T. Nakagami, S. Morikawa, T. Takahashi, T. Ueyama, H. Matsubara, et al. Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration J. Cell Sci., May 15, 2007; 120(10): 1791 - 1800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Anversa, A. Leri, M. Rota, T. Hosoda, C. Bearzi, K. Urbanek, J. Kajstura, and R. Bolli Concise Review: Stem Cells, Myocardial Regeneration, and Methodological Artifacts Stem Cells, March 1, 2007; 25(3): 589 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lehrke, R. Mazhari, D. J. Durand, M. Zheng, D. Bedja, J. M. Zimmet, K. H. Schuleri, A. S. Chi, K. L. Gabrielson, and J. M. Hare Aging Impairs the Beneficial Effect of Granulocyte Colony-Stimulating Factor and Stem Cell Factor on Post-Myocardial Infarction Remodeling Circ. Res., September 1, 2006; 99(5): 553 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Highlights From The Literature Physiology, August 1, 2006; 21(4): 229 - 232. [Full Text] [PDF]
|
|
|
|
|
|
H.-J. Cho and Y.-s. Yoon Synergism of Hematopoietic Cytokines for Infarct Repair Circ. Res., April 28, 2006; 98(8): 990 - 992. [Full Text] [PDF]
|
|